A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Castration-resistant Prostate Cancer|Metastatic Breast Cancer
Interventions: DRUG: Abiraterone acetate|DRUG: Prednisone
Sponsor: Janssen Research & Development, LLC